These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2004-001605-10 A Phase II, open-label study of PTK787/ZK222584 in the treatment of metastatic gastrointestinal stromal tumors GISTs resistant to imatinib mesylate not-yet-due
Ongoing 2005-000833-39 RANDOMIZED STUDY WITH POSTOPERATIVE RADIOTHERAPY AND CONCURRENT LOW DOSE CISPLATIN VS RADIOTHERAPY AND CONCURRENT CISPLATIN + FLUOROURACIL IN OPERATED HIGH RISK SQUAMOUS CELL CARCINOMA OF THE ... not-yet-due
Ongoing 2005-000838-21 RANDOMIZED STUDY OF RADIOTHERAPY WITH CONCOMITANT BOOST (RTcb) AND CONCURRENT LOW DOSE CISPLATIN VS RTcb AND CISPLATIN + FLUOROURACIL IN ADVANCED HNSCC not-yet-due
Ongoing 2005-003369-17 A phase II Multi-Dose Study of SGN-30 anti-CD30 mAb in Patients with Refractory or Recurrent Hodgkin s Disease or Anaplstic Large Cell Lymphoma not-yet-due
Ongoing 2005-003676-38 CAPECITABINE TIME TABLE AND RADIOTHERAPY AS ADJUVANT THERAPY IN RECTAL CANCER not-yet-due
Completed, but no date 2005-003701-91 ONCE WEEKLY DOSING OF DARBEPOETIN ALPHA AS PROPHYLACTIC TREATMENT FOR ANEMIA IN ELDERLY CANCER PATIENTS bad-data
Ongoing 2006-003151-21 Study to compare the tolerability of slow release oxycodone versus slow release morphine in the treatment of severe cancer pain. The study is geared towards a clinical practice improvement. not-yet-due
Completed, but no date 2006-004234-33 Intensive chemo-immunotherapy as first-line treatment in adult patients with peripheral T-cell Lymphoma PTCL bad-data
Ongoing 2006-005009-69 TRABECTEDIN (ET743) IN METASTATIC OR LOCALLY ADVANCED MYXOID/ROUND CELL LIPOSARCOMA PRETREATED WITH CHEMOTHERAPY not-yet-due
Completed, but no date 2007-003657-87 Reduced intensity conditioning with high-dose rituximab followed by allogeneic transplantation of hematopoietic cells for the treatment of relapsed/refractory B-cell non Hodgkin’s lymphomas bad-data
Completed, but no date 2008-000080-42 A Phase II study of Chetoconazolo in patients with Metastatic Hormone-Refractory Prostate Cancer. Pilot study bad-data
Ongoing 2008-001062-93 Perioperative treatment with COI-E (capecitabine, oxaliplatin, irinotecan and cetuximab) of liver metastasis of colorectal carcinoma potentially resectable although at high risk of recurrences not-yet-due
Ongoing 2008-002202-18 CALENDULA POMADE VERSUS PLACEBO CREAM/CORTISONE CREAM (FLUORCORTOLONE) IN THE PREVENTION OF CUTANEOUS ERYTHEMA DUE TO BREAST IRRADIATION. A RANDOMIZED STUDY ON 60 PATIENTS not-yet-due
Ongoing 2008-002454-37 intrarterial chemotherapy with liposomial doxorubicin for recurrent glioblastoma affected patients. Phase II study. not-yet-due
Ongoing 2008-005176-28 A PROSPECTIVE PHASE II MULTICENTRIC STUDY OF WEEKLY TOPOTECAN AND CISPLATIN (TOPOCIS) AS NEOADJUVANT TREATMENT IN PATIENTS WITH LOCALLY ADVANCED SQUAMOUS CERVICAL CANCER not-yet-due
Ongoing 2008-006527-30 Preventing Breast cancer through Assumption of Metformin, Diet and Physical Activity not-yet-due
Ongoing 2009-009418-42 Phase II study evaluating efficacy and tolerability of Sorafenib in the treatment of iatrogenic lymphedema occurring in breast cancer patients following surgical dissection of, and/or radiotherapy on ... not-yet-due
Ongoing 2009-014301-14 Farmacologic prevention with Varenicline in heavy smokers undergoing early detection lung cancer screening not-yet-due
Ongoing 2009-014456-29 PHASE II STUDY OF LAPATINIB IN EGFR/HER2NEU POSITIVE ADVANCED CHORDOMA not-yet-due
Completed, but no date 2009-015909-39 Phase I/II trial of dexamethasone, ofatumumab and bendamustine [Treanda] (DOT) as first-line treatment of mantle-cell lymphoma (MCL) in the elderly bad-data
Ongoing 2009-017093-20 Phase 2 study with the multi-targeted tyrosine-kinase inhibitor Pazopanib (GW786034) for patients with relapsed or refractory urothelial cancer not-yet-due
Ongoing 2009-017798-39 An open label, Phase II study of vaccination with Survivin peptides emulsified in Montanide ISA 51VG after IMP 321 injection in prostate carcinoma patients with biochemical failure (PROVAX study) not-yet-due
Ongoing 2010-018869-29 Phase II study of nilotinib efficacy in Pigmented Villo-Nodular Synovitis / Tenosynovial Giant Cell Tumor (PVNS / TGCT) not-yet-due
Ongoing 2010-020305-32 A phase II, open label study to evaluate the activity and safety of Everolimus in association to Imatinib in PDGFRA-D842V unresectable or metastatic gastrointestinal stromal tumours (GISTs)as fi... not-yet-due
Ongoing 2010-020375-24 Sorafenib in recurrent and/or metastatic salivary gland carcinomas not-yet-due
Completed, but no date 2010-021557-40 A phase III trial comparing bortezomib, cyclophosphamide and dexamethasone versus lenalinomide cyclophosphamide and dexamethasone in patients with multiple myeloma at first relapse bad-data
Ongoing 2010-021658-21 Phase II study of preoperative TPF chemotherapy in locally advanced resectable oral cavity squamous cell cancer in order to improve the rate of pathological complete response not-yet-due
Ongoing 2010-021755-34 Phase II study on imatinib in combination with RAD001 in advanced chordoma not-yet-due
Ongoing 2010-021898-36 Tandem high-dose chemotherapy (HDCT) with peripheral-blood stem-cell rescue for patients with metastatic germ-cell tumors failing first-line treatment. not-yet-due
Ongoing 2010-022653-41 Phase II study of neoadjuvant cisplatin and gemcitabine plus sorafenib for patients with transitional cell carcinoma of the bladder. not-yet-due
Ongoing 2010-023135-42 INTERNATIONAL RANDOMIZED PHASE II TRIAL OF THE COMBINATION OF VINCRISTINE AND IRINOTECAN WITH OR WITHOUT TEMOZOLOMIDE (VI OR VIT) IN CHILDREN AND ADULTS WITH REFRACTORY OR RELAPSED RHABDOMYOSARCOMA not-yet-due
Ongoing 2011-002564-24 Cetuximab and Cisplatin with or without Paclitaxel in recurrent/metastatic head and neck cancer not-yet-due
Ongoing 2011-002632-99 SUTNET Trial: Biological and Clinical Phase II study of Sunitinib in patients with unresectable and/or metastatic pheochromocytoma/paraganglioma not-yet-due
Ongoing 2011-005248-81 Differentiated thyroid cancer: metabolic radiotherapy with high activity of radioiodine calculated by individual pre-therapy dosimetry not-yet-due
Ongoing 2011-005327-41 Clinical trial randomized and controlled to compare the analgesic efficacy of the association zoledronic acid and 153Sm-lexidronam vs zoledronic acid in patients with skeletal metastases from hormono-... not-yet-due
Ongoing 2011-005983-12 Phase II study of the fully human monoclonal antibody against transforming growth factor-beta (TGF-beta) receptor ALK1 (PF-03446962) in relapsed or refractory urothelial cancer (UC) failing first-line... not-yet-due
Ongoing 2011-006205-95 Toremifene in desmoid tumor: prospective clinical trial and identification of potential molecular targets not-yet-due
Ongoing 2011-006234-16 Evaluation of the efficacy of the tandem treatment [90Y-DOTA, TYR(3)]OCTREOTATE and [177Lu-DOTA, TYR(3)]OCTREOTATE in patients with neuroendocrine tumour expressing somatostatin receptors and refracto... not-yet-due
Ongoing 2012-000382-20 Peritoneal Mesothelioma: Optimize Outcomes by the Integration of new Prognostic Factors and Potential Therapeutic Targets in a Individualized Treatment based on Molecular Characterization and Chemosen... not-yet-due
Ongoing 2012-000708-14 A randomized, open label, multicenter phase 2 study, to evaluate the efficacy of Sorafenib in patients with advanced Renal Cell Carcinoma (RCC) after a radical resection of the metastases. not-yet-due
Ongoing 2012-001103-21 MANTAINANCE METRONOMIC PER OS NAVELBINE IN ADVANCED NSCLC PATIENTS AFTER PREVIOUS PLATINUM BASED CHEMOTHERAPY: A MULTICENTER RANDOMIZED BEST SUPPORTIVE CARE CONTROLLED PHASE II STUDY: MA.NI.LA. TRIAL.... not-yet-due
Not reported 2012-002059-40 Potentiating clinical and immunological effects of chemotherapy by neutralizing acidic pH at tumor site: a phase II randomized study in melanoma patients 2013-06-20 due-trials
Completed, but no date 2012-002460-27 Preoperative skin preparation to lower surgical site infection in breast cancer surgery: Povidone – iodine 10% aqueous solution versus 2%chlorhexidine in 70% isopropyl alcohol (ChloraPrep, Cardinal H... bad-data
Ongoing 2012-003590-25 Phase II study of the Pan-HER inhibitor Dacomitinib (PF-00299804) for patients with locally advanced or metastatic squamous cell carcinoma of the penis not-yet-due
Completed, but no date 2012-004910-33 Phase II study of single-agent Pazopanib (Votrient) for patients with relapsed or refractory germ-cell tumors (GCT). bad-data
Completed, but no date 2012-004956-12 A phase II, open label, single arm trial of neoadjuvant therapy in patients with triple negative breast cancer evaluating the efficacy of eribulin mesylate following anthracycline and taxane and corre... bad-data
Completed, but no date 2012-005157-23 A Phase I/II Study of Danusertib in Combination with Romidepsin in Adult Patients with Mature Peripheral T Cell Lymphoma (PTCL) bad-data
Ongoing 2012-005427-32 Randomized controlled trial of metformin and dietary restriction to prevent age-related morbid events in people with metabolic syndrome not-yet-due
Ongoing 2013-000075-33 Multidisciplinary approach for poor prognosis sinonasal tumors: Phase II study of chemotherapy, surgery, photon and heavy ion radiotherapy integration for more effective and less toxic treatment in op... not-yet-due
Ongoing 2013-000580-93 Multidisciplinary approach for poor prognosis sinonasal tumors: Phase II study of chemotherapy, photon and heavy ion radiotherapy integration for more effective and less toxic treatment in inoperable ... not-yet-due
Ongoing 2013-001362-42 Perioperative treatment with COI-B (Capecitabine, Oxaliplatin, Irinotecan and Bevacizumab) of high risk or borderline resectable colorectal liver metastases not-yet-due
Ongoing 2013-003319-23 SUBLINGUAL FENTANYL VERSUS SUBCUTANEOUS MORPHINE not-yet-due
Ongoing 2013-005282-39 Effects of high Intra-abdominal pressure on tissue diffusion and pharmacokinectics of cisplatin during HIPEC not-yet-due
Completed, but no date 2013-005309-30 open label, randomized, pilot study on the activity of olanzapine with or without delayed dexamenthasone versus dexamenthasone alone for the prevention of delayed nausea and vomiting in patients with ... bad-data
Ongoing 2013-005596-40 Phase II Study of Axitinib in Advanced Solitary Fibrous Tumor not-yet-due
Ongoing 2014-000043-32 A Phase 2 study of Paclitaxel and Ifosfamide plus either Cisplatin or Carboplatin for patients with metastatic non-transitional cell carcinoma of the bladder and the urinary tract not-yet-due
Completed, but no date 2014-000334-30 Immunomodulatory effect of esomeprazole antitumoral and high-dose under neoadjuvant and adjuvant in patients with melanoma in stage III. Randomized pilot study treatment vs control bad-data
Completed, but no date 2014-000557-36 A Phase 2 study of the Aurora kinase A inhibitor Alisertib (MLN8237) in patients with relapsed or refractory transitional-cell carcinoma of the bladder and urothelial tract bad-data
Completed, report not yet due 2014-000777-38 Activity and safety of second line SOrafenib After Pazopanib in patients with metastatic renal cell carcinoma (SOAP Study) 2017-11-08 not-yet-due
Ongoing 2014-000857-35 An open label, randomized, phase 2 study of Paclitaxel and Panitumumab compared to Paclitaxel alone in patients with relapsed or refractory urothelial cancer. not-yet-due
Ongoing 2014-001274-34 Phase II trial of abiraterone acetate in patients with relapsed and/or metastatic, castration resistant, salivary gland cancers. not-yet-due
Completed, report not yet due 2014-001956-52 Activity and safety of third line tyrosin kinase inhibitor (TKI) after 2 tyrosin kinase inhibitors(TKIs) in patients with metastatic renal cell carcinoma (mRCC) (Tokio Study) 2017-11-08 not-yet-due
Ongoing 2014-002021-35 Decurarization After Thoracic Anesthesia - A prospective multicenter double-blind randomized trial comparing sugammadex vs neostigmine reversal after thoracic anesthesia not-yet-due
Ongoing 2014-002175-28 Efficacy and safety of single agent pan-HER inhibitor Dacomitinib in the treatment of locally advanced unresectable or metastatic squamous cell cancer of the skin or with clinical contraindication to... not-yet-due
Ongoing 2014-002417-36 An open-label, randomized, multicenter, phase II trial designed to estimate the activity of CAPTEM combination versus FOLFIRI as second line treatment in patients who have progressed on or after first... not-yet-due
Ongoing 2014-003227-21 Phase II study on Inlyta® (axitinib) in recurrent and/or metastatic salivary gland cancers (SGCs) of the upper aerodigestive tract not-yet-due
Ongoing 2015-004472-30 Randomized phase III trial on Trabectedin (ET-743) vs clinician's choice chemotherapy in recurrent ovarian, primary peritoneal or fallopian tube cancers of BRCA mutated or BRCAness phenotype patients ... not-yet-due